Skip to content

Author

Y.-H. Liang

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Nov 2026

A phase I/II study using cabozantinib and lanreotide as treatments for advanced GEP-NETs for which molecular targeted therapy or chemotherapy have failed (SCALET): TCOG T2221 study.

BACKGROUND Somatostatin analogs (SSAs) and targeted therapies have shown efficacy for advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in the past decades. To explore the therapeutic efficacy of SSA and targeted therapy combination, we conducted a phase I/II study to evaluate the toxicity and efficacy o...

Hui-Jen Tsai, M.-H. Chen, Cheng-Fang Hsiao et al. · 0 citations
Open access Aug 2026

Adjuvant chemotherapy with or without targeted therapy for patients with resectable synchronous colon cancer and liver or lung-confined metastases: a nationwide Taiwanese database study

Background The efficacy of targeted therapies in patients with resectable synchronous colon cancer and liver- or lung-confined metastasis (SCCLM) following curative surgery remains unclear. Patients and methods A population-based cohort of patients with de novo SCCLM diagnosed between 2014 and 2022 was established usin...

Ping-Yang Chen, Y.-H. Liang, B.-R. Lin et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.